NERVGEN PHARMA CORP. (NGEN) Form 10-K Annual Reports
NERVGEN PHARMA CORP. (NGEN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NGEN
CIK: 1751912
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerSteven Douglas
Audit LocationVancouver, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K/A | 2026-10-16 | 2026-08-13 | FORM 6-K/A | 0001104659-26-116634 | View SEC Doc Filr Page |
| 40-F/A | 2026-10-16 | 2025-12-31 | 40-F/A | 0001104659-26-116627 | View SEC Doc Filr Page |
| 6-K | 2026-09-25 | 2026-09-25 | FORM 6-K | 0001104659-26-111004 | View SEC Doc Filr Page |
| 6-K | 2026-09-24 | 2026-09-24 | FORM 6-K | 0001104659-26-110225 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-13 | FORM 6-K | 0001104659-26-095467 | View SEC Doc Filr Page |
| 6-K | 2026-07-02 | 2026-07-02 | FORM 6-K | 0001104659-26-080432 | View SEC Doc Filr Page |
| SUPPL | 2026-07-02 | — | SUPPL | 0001104659-26-080430 | View SEC Doc Filr Page |
| 6-K | 2026-06-01 | 2026-06-01 | FORM 6-K | 0001104659-26-069028 | View SEC Doc Filr Page |
| EFFECT | 2026-05-26 | — | EFFECT Filing | 9999999995-26-001763 | View SEC Doc Filr Page |
| 6-K | 2026-05-26 | 2026-05-26 | FORM 6-K | 0001104659-26-066307 | View SEC Doc Filr Page |
| SUPPL | 2026-05-26 | — | SUPPL | 0001104659-26-066304 | View SEC Doc Filr Page |
| F-X | 2026-05-26 | — | FORM F-X | 0001104659-26-066079 | View SEC Doc Filr Page |
| F-10 | 2026-05-26 | — | F-10 | 0001104659-26-066063 | View SEC Doc Filr Page |
| 6-K | 2026-05-22 | 2026-05-22 | FORM 6-K | 0001104659-26-065821 | View SEC Doc Filr Page |
| SUPPL | 2026-05-22 | — | SUPPL | 0001104659-26-065817 | View SEC Doc Filr Page |
| SUPPL | 2026-05-21 | — | SUPPL | 0001104659-26-065185 | View SEC Doc Filr Page |
| 6-K | 2026-05-18 | 2026-05-18 | FORM 6-K | 0001104659-26-063212 | View SEC Doc Filr Page |
| 6-K | 2026-05-15 | 2026-05-15 | FORM 6-K | 0001104659-26-062618 | View SEC Doc Filr Page |
| S-8 | 2026-05-07 | — | FORM S-8 | 0001104659-26-057111 | View SEC Doc Filr Page |
| 6-K | 2026-04-27 | 2026-04-27 | FORM 6-K | 0001104659-26-049508 | View SEC Doc Filr Page |
| 40-F | 2026-03-31 | 2025-12-31 | 40-F | 0001104659-26-037357 | View SEC Doc Filr Page |
| 6-K | 2026-03-13 | 2026-03-13 | FORM 6-K | 0001104659-26-027740 | View SEC Doc Filr Page |
| 6-K | 2026-02-13 | 2026-02-13 | FORM 6-K | 0001104659-26-015192 | View SEC Doc Filr Page |
| 6-K | 2026-02-10 | 2026-02-10 | FORM 6-K | 0001104659-26-012610 | View SEC Doc Filr Page |
| S-8 | 2026-01-23 | — | FORM S-8 | 0001104659-26-006289 | View SEC Doc Filr Page |